Navidea declares Series K Preferred Stock dividend with super-voting rights on reverse split

NAVIDEA BIOPHARMACEUTICALS, INC.

Dividend of 1/1,000th of Series K Preferred per common share, record date June 27, 2023.
Each Series K share carries 1,000,000 votes, voting only on a proposed reverse stock split.
Series K non-transferable except with common shares; redeemed after reverse split vote.
Dividend grants common holders extra voting power to facilitate reverse split approval.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

NAVIDEA BIOPHARMACEUTICALS, INC.: Designation of Series K Preferred Stock via a Certificate of Designation; declaration of a dividend of Series K Preferred Stock for common stockholders; this is a stock rights plan/dividend, not an amendment to charter or bylaws (effective 2023-06-16).

Change: bylaw amendment
Effective: 2023-06-16

Exact text from the filing

declared a dividend of one one-thousandth of a share of Series K Preferred Stock, par value $0.001 per share

View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR

accession 0001437749-23-017745

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.